Download
Heinze-et-al_2023_German mammography screening program.pdf 980,27KB
WeightNameValue
1000 Titel
  • German mammography screening program: program sensitivity between 2010 and 2016 estimated based on German health claims data
1000 Autor/in
  1. Heinze, Franziska |
  2. Czwikla, Jonas |
  3. Heinig, Miriam |
  4. Langner, Ingo |
  5. Haug, Ulrike |
1000 Erscheinungsjahr 2023
1000 LeibnizOpen
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2023-09-11
1000 Erschienen in
1000 Quellenangabe
  • 23(1):852
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2023
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12885-023-11378-0 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496211/ |
1000 Ergänzendes Material
  • https://bmccancer.biomedcentral.com/articles/10.1186/s12885-023-11378-0#Sec13 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: Program sensitivity is a key quality indicator for mammography screening programs (MSP). Estimating program sensitivity usually requires a linkage of screening and cancer registry data. For the German MSP, such data linkage-based estimates have only been reported for two out of 16 federal states. We aimed to explore the potential of estimating program sensitivity for the German MSP based on information available in health claims data. METHODS: We used data from the second-largest statutory health insurance fund in Germany, BARMER (~ 9 million members all over Germany). We included women aged 50 to 69 years with a non-initial screening mammography between 2010 and 2016 and followed them up for two years. We estimated the rate of screen-detected and interval cancers as well as program sensitivity. RESULTS: Per year, we included 212,400 to 303,667 women (mean age: 60–61 years). Overall, 1,992,287 non-initial MSP screening examinations conducted in these women between 2010 and 2016 were considered for the analyses. Age-standardized program sensitivity ranged between 69.9% [95% CI: 67.3–72.0%] and 71.7% [95% CI: 69.5-73.9%] during the study period. Per 1,000 non-initial screening examinations, the rate of screen-detected breast cancer ranged between 4.6 and 5.3, and the rate of interval breast cancer rates ranged between 0.6 and 0.8 for the first and between 1.3 and 1.4 for the second year after screening. CONCLUSIONS: Our results were plausible and consistent with quality indicators estimated for the German MSP based on data linkage and thus support the value of German health claims data in this regard. The quality indicators estimated in our study are in line with levels expected according to European Guidelines.
1000 Sacherschließung
lokal Mammography
lokal Claims data
lokal Breast cancer
lokal Screening
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/SGVpbnplLCBGcmFuemlza2E=|https://frl.publisso.de/adhoc/uri/Q3p3aWtsYSwgSm9uYXM=|https://orcid.org/0000-0001-7071-6715|https://frl.publisso.de/adhoc/uri/TGFuZ25lciwgSW5nbw==|https://orcid.org/0000-0002-1886-2923
1000 Label
1000 Förderer
  1. Projekt DEAL |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. Open Access funding
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Projekt DEAL |
    1000 Förderprogramm Open Access funding
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6473143.rdf
1000 Erstellt am 2024-02-09T12:19:39.238+0100
1000 Erstellt von 266
1000 beschreibt frl:6473143
1000 Bearbeitet von 317
1000 Zuletzt bearbeitet Thu Feb 29 11:19:18 CET 2024
1000 Objekt bearb. Thu Feb 29 11:19:02 CET 2024
1000 Vgl. frl:6473143
1000 Oai Id
  1. oai:frl.publisso.de:frl:6473143 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source